Business Description
Founded in 2012 and headquartered in Qingdao, China, B&K Corporation Limited is a biopharmaceutical company focused on developing protein-based medicines to treat a wide range of wounds and related conditions. Its lead program centers on platelet-derived growth factor therapies, with two advanced candidates targeting burn injuries and diabetic foot ulcers currently progressing through clinical trials. Beyond these, the company has built a broader portfolio of treatments in various forms ? including gels, sprays, eye drops, and injections ? aimed at conditions such as pressure sores, dry eye, hair loss, and stomach ulcers.
